Cited by 972Cancer-related Molecular PathwaysDNA Repair MechanismsHeat shock proteins research

The DOI matches its Crossref record; 78 of the 84 references it cites were found in a registry or an index.

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Open access

Shieh, Sheau-Yann, Ahn, Jinwoo, Tamai, Katsuyuki, Taya, Yoichi, Prives, Carol·2000·Genes & Development

Open this paper in CoChat — free account Open PDF

Abstract

Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein. Because no known kinase has been identified that can modify this site, HeLa nuclear extracts were fractionated and S20 phosphorylation was followed. We discovered that a S20 kinase activity copurifies with the human homolog of the Schizosaccharomyces pombe checkpoint kinase, Chk1 (hCHK1). We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase. It is interesting that hCHK1 strongly prefers tetrameric to monomeric p53 in vitro, consistent with our observation that phosphorylation of amino-terminal sites in vivo requires that p53 be oligomeric. Regulation of the levels and activity of hCHK1 in transfected cells is directly correlated with the levels of p53; expression of either a kinase-defective hCHK1 or antisense hCHK1 leads to reduced levels of cotransfected p53, whereas overexpression of wild-type hCHK1 or the kinase domain of hCHK1 results in increased levels of expressed p53 protein. The human homolog of the second S. pombe checkpoint kinase, Cds1 (CHK2/hCds1), phosphorylates tetrameric p53 but not monomeric p53 in vitro at sites similar to those phosphorylated by hCHK1 kinase, suggesting that both checkpoint kinases can play roles in regulating p53 after DNA damage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.14.3.289

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Another p53 target gene, MDM2, encodes a p53-binding protein that negatively regulates the activity (Momand et al. 1992; Oliner et al. 1993) and the stability of p53 (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
Background
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citation
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Self-citation
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citation
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474

Show all 84 references

Research works printed but not linked: 1

Mayo, 1997, Mdm2 phosphorylation by DNA-dependent protein kinase prevents ineraction with p53., Cancer Res., 57, 5013

Sorted by citations

Items 301–400 of 964

FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Cui, D., Xiong, X., Shu, J., Dai, X.-Q., Sun, Y., & Zhao, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.12.032 · Cited by 82
Inactivation of Cdc7 kinase in mouse ES cells results in S‐phase arrest and p53‐dependent cell death
Kim, J. M., Nakao, K., Nakamura, K. D., Saito, I., Katsuki, M., Arai, K., & Masai, H. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2168 · Cited by 81
Reviving the guardian of the genome: Small molecule activators of p53
Nguyen, D., Liao, W., Zeng, S. X., & Lu, H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.013 · Cited by 84
The role of arginine methylation in the DNA damage response
Auclair, Y., & Richard, S. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.006 · Cited by 81
ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks
Khalil, A. A., Morgan, R. N., Adams, B. R., Golding, S. E., Dever, S. M., Rosenberg, E., Povirk, L. F., & Valerie, K. C. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14713 · Cited by 80
Checkpoint Kinase 2 (Chk2) Monomers or Dimers Phosphorylate Cdc25C after DNA Damage Regardless of Threonine 68 Phosphorylation
Ahn, J., & Prives, C. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208321200 · Cited by 82
Self-citation
Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer.
Haruki, N., Saito, H., Tatematsu, Y., Konishi, H., Harano, T., Masuda, A., Osada, H., Fujii, Y., & Takahashi, T. (2000) · PubMed · Cited by 80
Cancer-associated p53 Tetramerization Domain Mutants
Kamada, R., Nomura, T., Anderson, C. W., & Sakaguchi, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174698 · Cited by 79
Indole‐3‐carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells
Brew, C. T., Aronchik, I., Hsu, J. C., Sheen, J.-H., Dickson, R. B., Bjeldanes, L. F., & Firestone, G. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.21445 · Cited by 79
In vivo p53 function is indispensable for DNA damage‐induced apoptotic signaling in Drosophila
Lee, J. H., Lee, E., Park, J., Kim, E., Kim, J., & Chung, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00771-3 · Cited by 79
New link in a web of human genes
Wang, J. Y. J. (2000) · Nature · doi:10.1038/35013171 · Cited by 79
Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
Vitale, I., Galluzzi, L., Vivet, S., Nanty, L., Dessen, P., Senovilla, L., Olaussen, K. A., Lazar, V., Prudhomme, M., Golsteyn, R. M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001337 · Cited by 77
RETRACTED ARTICLE: p73α Regulation by Chk1 in Response to DNA Damage
González, S., Prives, C. L., & Cordon‐Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 77
Self-citation
Retracted
Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53
Dornan, D., Eckert, M. J., Wallace, M., Shimizu, H., Ramsay, E., Hupp, T. R., & Ball, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.10083-10098.2004 · Cited by 77
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78
Cell and tissue responses to genotoxic stress
Coates, P. J., Lorimore, S. A., & Wright, E. G. (2005) · The Journal of Pathology · doi:10.1002/path.1701 · Cited by 77
Wip1 confers G2 checkpoint recovery competence by counteracting p53‐dependent transcriptional repression
Lindqvist, A., de Bruijn, M., Macurek, L., Brás, A., Mensinga, A., Bruinsma, W., Voets, O., Kranenburg, O., & Medema, R. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.246 · Cited by 75
Phosphorylation and hsp90 Binding Mediate Heat Shock Stabilization of p53
Wang, C., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206697200 · Cited by 75
30 years and a long way into p53 research
Hainaut, P. L., & Wiman, K. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70198-6 · Cited by 80
Detection of 11 germline inactivating TP53 mutations and absence of TP63 andHCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome
Bougeard, G., Limacher, J. M., Martin, C., CHARBONNIER, F., Killian, A., Delattre, O., Longy, M., Jonveaux, P., FRICKER, J.-P., Stoppa‐Lyonnet, D., et al. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.4.253 · Cited by 75
Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover
Dumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
Martinez-Rivera, M., & Siddik, Z. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.026 · Cited by 80
Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.
Sakai, M., Sohda, M., Miyazaki, T., Suzuki, S., Sano, A., Tanaka, N., Inose, T., Nakajima, M., Kato, H., & Kuwano, H. (2010) · PubMed · Cited by 74
A TPR Motif Cofactor Contributes to p300 Activity in the p53 Response
Demonacos, C., Krstic–Demonacos, M., & Thangue, N. B. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00277-5 · Cited by 76
Face off against ROS : Tcof1 /Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development
Sakai, D., & Trainor, P. A. (2016) · Development Growth & Differentiation · doi:10.1111/dgd.12305 · Cited by 78
Multiple actions of pifithrin-α on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells
Chua, C. C., Liu, X., Gao, J., Hamdy, R. C., & Chua, B. H. L. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01138.2005 · Cited by 74
Karyopherin-α2 Protein Interacts with Chk2 and Contributes to Its Nuclear Import
Zannini, L., Lecis, D., Lisanti, S., Benetti, R., Buscemi, G., Schneider, C., & Delia, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303304200 · Cited by 73
Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
Cheng, Q., Cross, B. L., Li, B., Chen, L., Li, Z., & Chen, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05553-11 · Cited by 78
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
Guo, N., Faller, D. V., & Vaziri, C. (2002) · PubMed · Cited by 73
p53CSV, a Novel p53-Inducible Gene Involved in the p53-Dependent Cell-Survival Pathway
Park, W.-R., & Nakamura, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3339 · Cited by 72
Human Cytomegalovirus IE1-72 Activates Ataxia Telangiectasia Mutated Kinase and a p53/p21-Mediated Growth Arrest Response
Castillo, J., Frame, F. M., Rogoff, H. A., Pickering, M., Yurochko, A. D., & Kowalik, T. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11467-11475.2005 · Cited by 72
Mutations in Proline 82 of p53 Impair Its Activation by Pin1 and Chk2 in Response to DNA Damage
Berger, M., Stahl, N., Sal, G. D., & Haupt, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5380-5388.2005 · Cited by 72
Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage‐induced S and G2 checkpoints and enhances apoptotic activity in HEK‐293 cells
Yu, Q., Rose, J. H. L., Zhang, H., & Pommier, Y. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02756-9 · Cited by 72
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage
Stefano, V. D., Soddu, S., Sacchi, A., & D’Orazi, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208717 · Cited by 73
The molecular control of DNA damage-induced cell death
Coultas, L., & Strasser, A. (2000) · APOPTOSIS · doi:10.1023/a:1009617727938 · Cited by 72
USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2
Wu, J., Chen, Y., Geng, G., Li, L., Yin, P., Nowsheen, S., Li, Y., Wu, C., Liu, J., Zhao, F., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.015 · Cited by 71
Meiotic Errors Activate Checkpoints that Improve Gamete Quality without Triggering Apoptosis in Male Germ Cells
Jaramillo-Lambert, A., Harigaya, Y., Vitt, J. R., Villeneuve, A. M., & Engebrecht, J. (2010) · Current Biology · doi:10.1016/j.cub.2010.10.008 · Cited by 71
DNA Structure and Integrity Checkpoints during the Cell Cycle and Their Role in Drug Targeting and Sensitivity of Tumor Cells to Anticancer Treatment
Składanowski, A., Bozko, P. M., & Sabisz, M. (2009) · Chemical Reviews · doi:10.1021/cr900026u · Cited by 74
CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
Sodha, N., Bullock, S. L., Taylor, R., Mitchell, G., Guertl‐Lackner, B., Williams, R. D., Bevan, S., Bishop, K., McGuire, S., Houlston, R. S., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600637 · Cited by 72
ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc
Russell, J. L., Powers, J. T., Rounbehler, R. J., Rogers, P. M., Conti, C. J., & Johnson, D. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1360-1368.2002 · Cited by 72
Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways
Gao, D., Inuzuka, H., Korenjak, M., Tseng, A., Wu, T., Wan, L., Kirschner, M. W., Dyson, N. J., & Wei, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0092 · Cited by 72
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 71
Ionizing radiation manifesting DNA damage response in plants: An overview of DNA damage signaling and repair mechanisms in plants
Kim, J., Ryu, T. H., Lee, S. S., Lee, S., & Chung, B. Y. (2018) · Plant Science · doi:10.1016/j.plantsci.2018.10.013 · Cited by 73
Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1
Park, H. U., Jeong, J., Chung, J. H., & Brady, J. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207644 · Cited by 74
Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners
Iwanaga, R., Komori, H., Ishida, S., Okamura, N., Nakayama, K., Nakayama, K., & Ohtani, K. (2005) · Oncogene · doi:10.1038/sj.onc.1209210 · Cited by 69
Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours
Bártková, J., Falck, J., Meyts, E. R., Skakkebæk, N. E., Lukas, J., & Bártek, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204746 · Cited by 69
p53 deficiency rescues apoptosis and differentiation of multiple cell types in zebrafish flathead mutants deficient for zygotic DNA polymerase δ1
Plaster, N. M., Sonntag, C., Busse, C. E., & Hammerschmidt, M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401747 · Cited by 70
Role of Dietary Antioxidants in p53‐Mediated Cancer Chemoprevention and Tumor Suppression
Merlin, J. P. J., Rupasinghe, H. P. V., Dellaire, G., & Murphy, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9924328 · Cited by 69
The Ataxia Telangiectasia–Mutated Target Site Ser18 Is Required for p53-Mediated Tumor Suppression
Armata, H. L., Garlick, D. S., & Sluss, H. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1610 · Cited by 69
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer
Ehlén, Õ., Nodin, B., Rexhepaj, E., Brändstedt, J., Uhlén, M., Alvarado-Kristensson, M., Pontén, F., Brennan, D. J., & Jirström, K. (2011) · Translational Oncology · doi:10.1593/tlo.11106 · Cited by 67
The Modified Human DNA Repair EnzymeO6-Methylguanine-DNA Methyltransferase Is a Negative Regulator of Estrogen Receptor-Mediated Transcription upon Alkylation DNA Damage
Teo, A. K.-C., Oh, H. K., Ali, R. B., & Li, B. F. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7105-7114.2001 · Cited by 67
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpointPreprint
Beckerman, R., Donner, A. J., Mattia, M., Peart, M. J., Manley, J. L., Espinosa, J. M., & Prives, C. L. (2009) · Genes & Development · doi:10.1101/gad.1795709 · Cited by 69
Self-citation
Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response
Cheng, Z., Ke, Y., Ding, X., Wang, F., Wang, H., Ahmed, K., Liu, Z., Xu, Y., Aikhionbare, F. O., Yan, H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210710 · Cited by 71
Deregulated CDC25A Expression Promotes Mammary Tumorigenesis with Genomic Instability
Ray, D., Terao, Y., Fuhrken, P. G., Ma, Z.-Q., DeMayo, F. J., Christov, K. T., Heerema, N. A., Franks, R. R., Tsai, S. Y., Papoutsakis, E. T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3927 · Cited by 66
Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage
Logan, I. R., McNeill, H. V., Cook, S., Lü, X., Meek, D. W., Fuller-Pace, F. V., Lunec, J., & Robson, C. N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp180 · Cited by 68
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner
Stewart, Z. A., Tang, L. J., & Pietenpol, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204060 · Cited by 68
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
Matin, R., Chikh, A., Chong, S. L. P., Mesher, D., Graf, M., Sanzà, P., Senatore, V., Scatolini, M., Moretti, F., Leigh, I. M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121439 · Cited by 66
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling
Sablina, A. A., Chumakov, P. M., Levine, A. J., & Kopnin, B. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204156 · Cited by 68
Autophosphorylation of Checkpoint Kinase 2 at Serine 516 Is Required for Radiation-induced Apoptosis
Wu, X., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303795200 · Cited by 70
Collaboration of Brca1 and Chk2 in tumorigenesisPreprint
McPherson, J. P., Lemmers, B., Hirao, A., Hakem, A., Abraham, J., Migon, E., Matysiak‐Zablocki, E., Tamblyn, L., Sanchez-Sweatman, O. H., Khokha, R., et al. (2004) · Genes & Development · doi:10.1101/gad.1192704 · Cited by 67
Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate
Wu, Y., Zhang, C., Xiong, J., Cai, D., Wang, C.-Z., Wang, Y., Liu, Y., Wang, Y., Li, Y., Wu, J. H., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00874-4 · Cited by 68
Synthesis of Imidazothiazole–Chalcone Derivatives as Anticancer and Apoptosis Inducing Agents
Kamal, Ä., Dastagiri, D., Ramaiah, M. J., Reddy, J., Bharathi, E. V., Chatla, S., Pushpavalli, S. N. C. V. L., Pal, D., & Pal‐Bhadra, M. (2010) · ChemMedChem · doi:10.1002/cmdc.201000346 · Cited by 64
DNA repair pathways and hereditary cancer susceptibility syndromes
Spry, M. L. (2007) · Frontiers in bioscience · doi:10.2741/2380 · Cited by 64
The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation
Ali, A., Abedini, M. R., & Tsang, B. K. (2011) · Oncogene · doi:10.1038/onc.2011.399 · Cited by 64
Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain
Craig, A. L., Scott, M. T., Burch, L. R., Smith, G. C. M., Ball, K. L., & Hupp, T. R. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor901 · Cited by 67
Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
Lee, J. H., Xu, B., Lee, C. H., Ahn, J.-Y., Song, M. S., Lee, H., Canman, C. E., Lee, J., Kastan, M. B., & Lim, D. (2003) · PubMed · Cited by 65
Self-citation
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
Ingvarsson, S., Sigbjornsdottir, B. I., Huiping, C., Hafsteinsdottir, S. H., Ragnarsson, G., Barkardottir, R. B., Arason, A., Egilsson, V., & Bergthorsson, J. T. (2002) · Breast Cancer Research · doi:10.1186/bcr435 · Cited by 63
Regulatory Interactions between the Checkpoint Kinase Chk1 and the Proteins of the DNA-dependent Protein Kinase Complex
Goudelock, D. M., Jiang, K., Pereira, E., Russell, B., & Sánchez, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301765200 · Cited by 69
Polo-like kinase-1 in DNA damage response
Hyun, S., Hwan, H.-I., & Jang, Y. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.5.061 · Cited by 66
CHEK2 1100delC is not a risk factor for male breast cancer population
Syrjäkoski, K., Kuukasjärvi, T., Auvinen, A. P., & Kallioniemi, O. (2003) · International Journal of Cancer · doi:10.1002/ijc.11384 · Cited by 63
DNA‐damage‐responsive acetylation of pRb regulates binding to E2F‐1
Markham, D., Munro, S., Soloway, J., O'Connor, D. P., & La Thangue, N. B. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400591 · Cited by 62
EDD Mediates DNA Damage-induced Activation of CHK2
Henderson, M. J., Munoz, M. A., Saunders, D. N., Clancy, J. L., Russell, A. J., Williams, B. L., Pappin, D., Khanna, K. K., Jackson, S. P., Sutherland, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602818200 · Cited by 64
Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV
Bean, L. J., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204204 · Cited by 63
The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair
Dai, Y., Chen, S., Kmieciak, M., Zhou, L., Lin, H., Pei, X., & Grant, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0902 · Cited by 61
Resolving DNA Damage: Epigenetic Regulation of DNA Repair
Karakaidos, P., Karagiannis, D., & Rampias, T. N. (2020) · Molecules · doi:10.3390/molecules25112496 · Cited by 64
Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif
Kim, M.-A., Kim, H., Brown, A. L., Lee, M.-Y., Bae, Y., Park, J., Kwak, J.-Y., Chung, J. H., & Yun, J. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.23 · Cited by 61
Oocyte Elimination Through DNA Damage Signaling from CHK1/CHK2 to p53 and p63
Rinaldi, V. D., Bloom, J. C., & Schimenti, J. C. (2020) · Genetics · doi:10.1534/genetics.120.303182 · Cited by 60
Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation
Jiang, H., Wu, J., He, C., Yang, W., & Li, H. (2009) · Cell Research · doi:10.1038/cr.2009.14 · Cited by 60
Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage
Bahassi, E. M., Myer, D. L., McKenney, R. J., Hennigan, R. F., & Stambrook, P. J. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.12.002 · Cited by 60
Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways
Blaydes, J. P., Craig, A. L., Wallace, M., Ball, H. M.-L., Traynor, N. J., Gibbs, N. K., & Hupp, T. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203773 · Cited by 60
Activation of ATM and phosphorylation of p53 by heat shock
Miyakoda, M., Suzuki, K., Kodama, S., & Watanabe, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205196 · Cited by 59
Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated–dependent and –independent mechanisms
Siu, W. Y., Lau, A. W. S., Arooz, T., Chow, J. P. H., Ho, H. T. B., & Poon, R. Y. C. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.621.3.5 · Cited by 59
Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint
Bigot, N., Day, M., Baldock, R. A., Watts, F. Z., Oliver, A. W., & Pearl, L. H. (2019) · eLife · doi:10.7554/elife.44353 · Cited by 59
Frequency of CHEK2 mutations in a population based, case–control study of breast cancer in young women
Friedrichsen, D. M., Malone, K. E., Doody, D. R., Daling, J. R., & Ostrander, E. A. (2004) · Breast Cancer Research · doi:10.1186/bcr933 · Cited by 60
The EBNA- 3 gene family proteins disrupt the G2/M checkpoint
Krauer, K. G., Burgess, A., Buck, M., Flanagan, J. M., Sculley, T. B., & Gabrielli, B. G. (2003) · Oncogene · doi:10.1038/sj.onc.1207253 · Cited by 59
Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 59
Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer.
Matsuoka, S., Nakagawa, T., Masuda, A., Haruki, N., Elledge, S. J., & Takahashi, T. (2001) · PubMed · Cited by 58
Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1
Qian, Y., Jung, Y.-S., & Chen, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203185109 · Cited by 59
Nucleotide Binding by the MDM2 RING Domain Facilitates Arf-Independent MDM2 Nucleolar Localization
Poyurovsky, M. V., Jacq, X., Ma, C., Karni-Schmidt, O., Parker, P. J., Chalfie, M., Manley, J. L., & Prives, C. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00400-3 · Cited by 58
Self-citation
Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints
Levesque, A. A., Kohn, E. A., Bresnick, E., & Eastman, A. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208451 · Cited by 57
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, T., & Dai, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180009 · Cited by 58
Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation
Kulkarni, A., & Das, K. C. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00004.2008 · Cited by 56
The role of the transcription factor DP in apoptosis
Hitchens, M. R., & Robbins, P. D. (2003) · APOPTOSIS · doi:10.1023/a:1025586207239 · Cited by 56
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Niida, H., Murata, K., Shimada, M., Ogawa, K., Ohta, K., Suzuki, K., Fujigaki, H., Khaw, A. K., Banerjee, B., Hande, M. P., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.218 · Cited by 56
hnRNP Q regulates translation of p53 in normal and stress conditions
Kim, D.-Y., Kim, W., Lee, K.-H., Kim, S.-H., Hr, L., Kim, H., Jung, Y., Choi, J., & KIM, K.-T. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.109 · Cited by 60
Genetic Landscape of Male Breast Cancer
Campos, F. A. B., Rouleau, É., Torrezan, G. T., Carraro, D. M., da Rocha, J. C. C., Mantovani, H. K., da Silva, L. R., Osório, C. A. B. D. T., Sanches, S. M., Caputo, S. M., et al. (2021) · Cancers · doi:10.3390/cancers13143535 · Cited by 58
Rituximab Enhances Radiation-Triggered Apoptosis in Non-Hodgkin's Lymphoma Cells Via Caspase-dependent and - Independent Mechanisms
Skvortsova, I., Skvortsov, S., Popper, B., Haidenberger, A., Saurer, M., Gunkel, A. R., Zwierzina, H., & Lukas, P. H. (2006) · Journal of Radiation Research · doi:10.1269/jrr.47.183 · Cited by 56
Human Cytomegalovirus Causes Endothelial Injury Through the Ataxia Telangiectasia Mutant and p53 DNA Damage Signaling Pathways
Shen, Y. H., Utama, B., Wang, J., Raveendran, M., Senthil, D., Waldman, W. J., Belcher, J. D., Vercellotti, G. M., Martin, D. P., Mitchelle, B. M., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000129180.13992.43 · Cited by 57
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
NFBD1/MDC1 Associates with p53 and Regulates Its Function at the Crossroad between Cell Survival and Death in Response to DNA Damage
Nakanishi, M., Ozaki, T., Yamamoto, H., Hanamoto, T., Kikuchi, H., Furuya, K., Asaka, M., Delia, D., & Nakagawara, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611412200 · Cited by 56

Authors: Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C.
Affiliations: Seisen University (JP)
ORCID: Shieh, Sheau-Yann
Tamai, Katsuyuki
Prives, Carol
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2000-02-01
Volume: 14
Issue: 3
Pages: 289-300
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.14.3.289
PMC: PMC316358
OpenAlex: W2120921507
Cited by: 972
References: 84
Citations by year: 2026: 11 · 2025: 4 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 24 · 2014: 39 · 2013: 38 · 2012: 42
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Princess Takamatsu Cancer Research Fund
National Institutes of Health (CA58316)
National Cancer Institute (R37CA058316, R01CA058316, CA 58316)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p53 phosphorylation, Chk1, Chk2, checkpoint kinase, DNA damage response, p53 oligomerization, p53 stabilization, Schizosaccharomyces pombe, kinase activity
MeSH terms: Checkpoint Kinase 1, DNA Damage, HeLa Cells, Humans, Phosphorylation, Protein Kinases, Recombinant Proteins, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Schizosaccharomyces pombe Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks